- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow DR. GERRY TAN Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1312532 [Title] => Managing diabetes [Summary] =>The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [1] => Array ( [ArticleID] => 378942 [Title] => Landmark diabetes trial seen to control blood sugar better [Summary] => You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00 [ColumnID] => 133560 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [2] => Array ( [ArticleID] => 375197 [Title] => Drug found to delay type 2 diabetes [Summary] => Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Cebu News [SectionUrl] => cebu-news [URL] => ) ) )
DR. GERRY TAN
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1312532 [Title] => Managing diabetes [Summary] =>The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [1] => Array ( [ArticleID] => 378942 [Title] => Landmark diabetes trial seen to control blood sugar better [Summary] => You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00 [ColumnID] => 133560 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [2] => Array ( [ArticleID] => 375197 [Title] => Drug found to delay type 2 diabetes [Summary] => Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Cebu News [SectionUrl] => cebu-news [URL] => ) ) )
abtest
By Maria Eleanor E. Valeros | April 14, 2014 - 12:00am
By Maria Eleanor E. Valeros | January 8, 2007 - 12:00am
December 15, 2006 - 12:00am
Recommended
NorthPort’s Arvin Tolentino, San Miguel’s June Mar Fajardo and NLEX’s Robert Bolick led the key statistical departments after the initial salvo in the PBA Commissioner’s Cup.
10 hours ago
Alex Eala is likely to finish among the world’s Top 150 in women’s tennis for the first time in her career.
10 hours ago
Junior tennis players are keeping their competitive spirits alive this holiday season as they vie for top honors and ranking points in the Palawan Pawnshop National Tennis Championships.
10 hours ago
Reinforcing the value of meaningful partnerships, Coca-Cola Beverages Phils. Inc. (CCBPI) and Coca-Cola Foundation Phils Inc. (CCFPI), together with valued stakeholders, once again came together to bolster support for community-focused projects through the 2024 Coca-Cola Golf Classic golf tournament.
10 hours ago
PBA deputy commissioner Eric Castro said yesterday the head coach challenge is a way to uplift the quality of officiating and isn’t necessarily a measure of rating a referee’s performance. The rule was introduced on an experimental basis during the PBA OnTour and applied starting the 2023 season.
10 hours ago
Lotto Dec 27, 2024
EZ2/LVM - 28 16
SUERTRES - 4 6 3
6D Lotto - 7 9 9 6
6/45 Lotto - 35 27 6 40 7 2
P48,552,861.00
6/58 Ultra Lotto - 55 21 2 19 28 15
P270,763,112.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66